Nonmyeloablative allogeneic bone marrow transplantation for treatment of childhood overlap syndrome and small vessel vasculitis

Bone Marrow Transplantation

Volumn 33, Issue 10, 2004, Pages 1061-1063

  Jones, O Y ^a   Good, R A ^a   Cahill, R A ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Cardinal Glennon Hospital   (United States)

Author keywords

Hematopoietic stem cells; Nonmyeloablative; Overlap syndrome; Stromal cells mesenchymal stem cells; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CELECOXIB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ENALAPRIL; FLUDARABINE; HUMAN GROWTH HORMONE; IMMUNOGLOBULIN; LEUPRORELIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PAMIDRONIC ACID;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; BONE TRANSPLANTATION; CASE REPORT; CLINICAL PROTOCOL; CONNECTIVE TISSUE DISEASE; CUSHING SYNDROME; DIARRHEA; ERYTHROCYTE; FATIGUE; FEMALE; GENERAL CONDITION IMPROVEMENT; HEMATOPOIETIC CELL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG BLOOD VESSEL; NAUSEA; NEUTROPENIA; OVERLAP SYNDROME; PRIORITY JOURNAL; RAYNAUD PHENOMENON; REMISSION; SMALL VESSEL VASCULITIS; STROMA CELL; TREATMENT FAILURE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; BONE TRANSPLANTATION; CONNECTIVE TISSUE DISEASES; CUSHING SYNDROME; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MESENCHYMAL STEM CELLS; MESODERM; STEM CELLS; STROMAL CELLS; SYNDROME; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VASCULITIS;

EID: 2942531262     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704482     Document Type: Article

References (16)

1. Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998; 83: 733-743.
2. Burt RK, Slavin S, Burns WH, Marmont AM. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood 2002; 99: 768-784.
3. Tyndall A, Koike T. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: current status and future direction. Intern Med 2002; 41: 608-612.
4. Eisenberg RA, Izui S, McConahey PJ et al. Male determined accelerated autoimmune disease in BXSB mice: transfer by bone marrow and spleen cells. J Immunol 1980; 125: 1032-1036.
5. Ikehara S, Kawamura M, Takao F et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 8341-8344.
6. Good RA, Verjee T. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Blood Marrow Transplant 2001; 7: 123-135.
7. Hinterberger W, Hinterberger-Fischer M, Marmont A. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Bone Marrow Transplant 2002; 30: 753-759.
8. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.
9. Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28: 853-857.
10. Marmont AM, Gualandi F, van Lint MT, Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31: 399-402.
11. Chakrabarti S, Handa SK, Bryon RJ et al. Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant? Transplantation 2001; 72: 340-342.
12. Oyama Y, Papadopoulos EB, Miranda M et al. Allogeneic stem cell transplantation for Evans syndrome. Bone Marrow Transplant 2001; 28: 903-905.
13. Chamarthy LM, de la Morena M, Lacson A et al. Pulmonary vasculitis presenting as atypical asthma. Ann Allergy Asthma Immunol 2000; 84: 495-498.
14. El-Badri NS, Wang BY, Cherry, Good RA. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol 1998; 26: 110-116.
15. Ishida T, Inaba M, Hisha H et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 1994; 152: 3119-3127.
16. Imasawa T, Utsunomiya Y, Kawamura T et al. The potential of bone marrow-derived cells to differentiate to glomerular amesangial cells. J Am Soc Nephrol 2001; 12: 1401-1409.